HomeInsightsStock Comparison

Gennex Laboratories Ltd vs Syncom Formulations India Ltd Stock Comparison

Gennex Laboratories Ltd vs Syncom Formulations India Ltd Stock Comparison

Last Updated on: Jun 10, 2025

Key Highlights

  • The Latest Trading Price of Gennex Laboratories Ltd is ₹ 13.15 as of 10 Jun 10:06.
  • The P/E Ratio of Gennex Laboratories Ltd changed from 24.3 on March 2022 to 12.2 on March 2021 . This represents a CAGR of -12.87% over 5 yearsThe P/E Ratio of Syncom Formulations (India) Ltd changed from 46.2 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Gennex Laboratories Ltd changed from ₹ 95.26 crore on March 2022 to ₹ 49.46 crore on March 2021 . This represents a CAGR of -12.29% over 5 yearsThe Market Cap of Syncom Formulations (India) Ltd changed from ₹ 916.79 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 years.
  • The revenue of Gennex Laboratories Ltd for the Mar '25 is ₹ 44.16 crore as compare to the Dec '24 revenue of ₹ 40.01 crore. This represent the growth of 10.37% The revenue of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 155.83 crore as compare to the Dec '24 revenue of ₹ 131.57 crore. This represent the growth of 18.44%.
  • The ebitda of Gennex Laboratories Ltd for the Mar '25 is ₹ 5.85 crore as compare to the Dec '24 ebitda of ₹ 7.15 crore. This represent the decline of -18.18% The ebitda of Syncom Formulations (India) Ltd for the Mar '25 is ₹ 24.7 crore as compare to the Dec '24 ebitda of ₹ 18.77 crore. This represent the growth of 31.59%.
  • The net profit of Gennex Laboratories Ltd changed from ₹ 2.85 crore to ₹ 3.07 crore over 8 quarters. This represents a CAGR of 3.79% The net profit of Syncom Formulations (India) Ltd changed from ₹ 4.4 crore to ₹ 17.69 crore over 8 quarters. This represents a CAGR of 100.51% .
  • The Dividend Payout of Gennex Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Syncom Formulations (India) Ltd changed from 13.07 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Gennex Laboratories Ltd

  • Gennex Laboratories Limited (formerly Prudential Pharmaceuticals Limited) was incorporated on June 25, 1985.
  • The Company got converted into a Public Limited Company and the name was changed from Prudential Pharmaceuticals Limited to Gennex Laboratories Limited in 2007. The Company is one of the leading manufacturers and exporters of Active pharmaceutical ingredients and Intermediates.
  • It is engaged in manufacturing and marketing of bulk drugs and intermediates. Gennex is among the leading Vertically Integrated' pharmaceutical companies in India and has a robust product portfolio spread over major product segments encompassing Expectorants, Muscle Relaxants, Analgesic and Anti Fungal.
  • The company thrives on the strength of its exports to various countries viz.
  • Germany, United Kingdom, Spain, Singapore, Canada, Switzerland, Iran, Bangladesh, Pakistan and Others.

About Syncom Formulations (India) Ltd

  • Incorporated as a private limited company in 1988, Syncom Formulations (India) Limited was converted into a public limited company in Jun.'92.
  • The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency.
  • Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur, Madhya Pradesh. Established in 1988, Syncom plant is geared up with latest production machineries and maintains high quality standards.
  • Currently, the Company manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments and Inhalers. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations.

Gennex Laboratories Ltd News Hub

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May...

Read more

21 May 2025 18:32

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Feb...

Read more

04 Feb 2025 10:33

News

Gennex Laboratories schedules board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Nov...

Read more

07 Nov 2024 14:11

News

Gennex Laboratories AGM scheduled

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company wi...

Read more

11 Sep 2024 17:20

News

Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 Sept...

Read more

28 Aug 2024 15:49

News

Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 Aug...

Read more

07 Aug 2024 17:36

Syncom Formulations (India) Ltd News Hub

News

Syncom Formulations (India) schedules board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

14 May 2025 14:06

News

Syncom Formulations (India) to convene board meeting

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

05 Nov 2024 14:12

News

Syncom Formulations (India) schedules AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 17:48

News

Syncom Formulations (India) to hold AGM

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company...

Read more

20 Sep 2024 10:30

News

Syncom Formulations gains after Q1 PAT rises over 73% YoY

Net sales rose by 45.8% year-over-year (YoY) during the quarter to Rs 87.26 crore. Total e...

Read more

13 Aug 2024 13:37

News

Syncom Formulations (India) announces board meeting date

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company o...

Read more

06 Aug 2024 11:37

SWOT Analysis Of Gennex Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Syncom Formulations (India) Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Gennex Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Syncom Formulations (India) Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Gennex Laboratories Ltd and Syncom Formulations (India) Ltd

Which company has a larger market capitalization, Gennex Laboratories Ltd or Syncom Formulations (India) Ltd?

Market cap of Gennex Laboratories Ltd is 299 Cr while Market cap of Syncom Formulations (India) Ltd is 2,014 Cr

What are the key factors driving the stock performance of Gennex Laboratories Ltd and Syncom Formulations (India) Ltd?

The stock performance of Gennex Laboratories Ltd and Syncom Formulations (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gennex Laboratories Ltd and Syncom Formulations (India) Ltd?

As of June 10, 2025, the Gennex Laboratories Ltd stock price is INR ₹13.18. On the other hand, Syncom Formulations (India) Ltd stock price is INR ₹21.43.

How do dividend payouts of Gennex Laboratories Ltd and Syncom Formulations (India) Ltd compare?

To compare the dividend payouts of Gennex Laboratories Ltd and Syncom Formulations (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions